Abstract Coronavirus disease 2019 (COVID-19), a respiratory viral infection, has affected
more than 78 million individuals worldwide as of the end of December 2020. Previous …

ABSTRACT COVID-19 is caused by SARS-CoV-2. Although pulmonary manifestations have
been identified as the major symptoms, several hematological abnormalities have also been …

Objectives Angiotensin-converting enzyme 2 (ACE2) represents the primary receptor for
SARS-CoV-2 to enter endothelial cells. Here we investigated circulating ACE2 activity to …

Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019
(COVID-19)(sometimes termed “long-COVID”), with up to 46% of patients reporting fatigue …

Background COVID-19 is now a worldwide pandemic. Among the many extra-pulmonary
manifestations of COVID-19, recent evidence suggested a possible occurrence of thyroid …

Recent studies showed that comorbidities such as diabetes, hypertension and obesity
contribute to severe and worse outcomes of coronavirus disease 2019 (COVID-19) …

The coronavirus disease 2019 (COVID19) pandemic continues to represent a substantial
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …

Endothelial cells express surface angiotensin-converting enzyme 2 (ACE2), the main
receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that promotes …

COVID-19, a respiratory viral infection, has affected 388 million individuals worldwide as of
the February 4, 2022. In this review, we have outlined the important liver manifestations of …

Introduction: The impact of long-COVID-19 syndrome is rather variable, since it is influenced
by several residual confounders. This study aimed to investigate the prevalence of long …